Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc. GLOBAL
  • About
    • Philosophy
      • Charter of Corporate Conduct
    • President and CEO’s Message
    • Vision & Strategy
    • Corporate Governance
      • Group Code of Conduct
    • Corporate Information
      • Subsidiaries & Locations
    • History
    • Board of Directors
    • Top Management
    • Main Products
    • Policies & Position Statements
    • Compliance Initiatives
    • Medical Care & Pharmaceutical Information
    Recommended
    Strategic Plan 2018
    Read More
  • Innovation
    • R&D
      • Approach
      • Ethics & Principles
      • Clinical Trials
      • Pipeline
    • Partnering
      • Track Record
      • Areas of Interest
      • Register Form
    Recommended
    Clinical Trials

    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...

    Read More
  • Responsibility
    • Our Commitment
      • United Global Compact
    • CSR-Based Management
      • Materiality
      • SDGs
      • ISO26000
      • 30% Club
    • Stakeholder Communications
      • Communication with the World Anti-Doping Agency (WADA)
    • CSR Activities in Five Fields
      • Business Activities
        • ISO certification status of Astellas plants
        • With our Business Partners
          • Basic policy for procurement activities involving suppliers
      • Modern Slavery Act 2015
      • Society
        • Advancement of Medical Sciences
        • Changing Tomorrow Day
        • Astellas Foundation
      • Environment
        • Definition of terms
        • EHS Management
          • Status of obtaining ISO 14001 Certification
          • Astellas Environment, Health & Safety Guidelines
        • Environment Initiatives
        • Climate Change Mitigation Measures
        • Breakdown of Energy Consumption
        • Sustainable Biodiversity Initiatives
          • Biodiversity and Astellas An Enlarged Version
          • The Biodiversity Burden Index and Revenue
        • Initiatives for Resource Recycling
        • Initiatives for Preventing Pollution
          • Further information on PRTR system
        • Environmental Impact of Products and Countermeasures
        • Environmental Accounting
          • Environment-related Investments and Expenses
        • Reporting coverage, methods, etc.
        • EHS Report
        • Independent Assurance Report
      • Employees
        • Development and Training
        • Developing Rewarding and Safe Work Environments
        • Human Rights
        • Occupational Health & Safety
        • Data
      • Ethics & Compliance
    • Access to Health
      • Research Activities on Tuberculosis and Malaria
      • Research Activities on NTDs
      • Access Accelerated
      • Action on Fistula
      • Development of Pediatric Formulation for Schistosomiasis
      • GHIT Fund
    • Awards & Recognition
    Recommended
    Access Accelerated

    Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving...

    Read More
  • News
    • News
    • Stories
    • Astellas Library
      • Corporate Video
      • ANA Inflight Program
      • New Global Corporate Commercial in Collaboration with Discovery Communications
    • Media Contacts
    Recommended
    Stories

    The “Story” section contains contents focused on “hero”: people (patients, employees, scientists, etc.), scientific innovation and social...

    Read More
  • Investors
    • Strategic Plan 2018
    • Financial Information
      • Financial Highlights
      • Financial Data (Annual Data)
      • Financial Data (Quarterly Data)
      • Sales of Major Products
      • Revenue by Region
    • Annual Report
    • IR Library
      • Business Results
      • Overview of R&D Pipeline
      • IR Meetings
      • Corporate Governance Materials
    • IR Calendar
    • Stock & Rating Information
      • Shareholders Meeting
      • Shareholder Return
      • Current Share Status
      • Chart
      • Issuer Rating
    • Cautionary Statement
    • Analyst Coverage
    Recommended
    Financial Information

    Review our consolidated business results, forecasts and financial data, etc.

    Read More

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  1. Home
  2. Investors
  3. IR Library
  4. Corporate Governance Materials

Corporate Governance Materials

Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree
logo
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.
  • Facebook
  • Linkedin
  • Twitter

Investors

  • Strategic Plan 2018
  • Financial Information
    • Financial Highlights
    • Financial Data (Annual Data)
    • Financial Data (Quarterly Data)
    • Sales of Major Products
    • Revenue by Region
  • Annual Report
  • IR Library
    • Business Results
    • Overview of R&D Pipeline
    • IR Meetings
    • Corporate Governance Materials
  • IR Calendar
  • Stock & Rating Information
    • Shareholders Meeting
    • Shareholder Return
    • Current Share Status
    • Chart
    • Issuer Rating
  • Cautionary Statement
  • Analyst Coverage

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • TERMS OF USE
  • CONTACT US
  • DISASTER INFORMATION FOR EMPLOYEES
© Astellas Pharma Inc.